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TRICYCLOQUINAZOLINE (TCQ) was synthesised by Cooper and Partridge
(1954) during investigations on cyclic amidines. This compound is built up of
three benzene rings and three pyrimidine rings fused together in such a way as
to yield a fully symmetrical structure (Fig. 1). As far as is known, it is unrelated
to any of the homocyclic or heterocyclic carcinogenic hydrocarbons hitherto
studied and is characterised by unusually high chemical stability. It is, for
example, resistant to oxidation and is stable to sublimation at red heat.
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FIG. 1.-Tricycloquinazoline.
More recently, it has been shown that TCQ is readily formed in simple pyro-
lytic reactions with a number of derivatives of anthranilic acid, including methyl
anthranilate (Baldwin et al., 1958). In view of the wide occurrence of methyl
anthranilate in plant materials (Klein, 1932) and the ease of production of TCQ
from it by combustion, it was considered essential to determine the carcinogenic
activity of TCQ. In a preliminary report (Baldwin et al., 1958) TCQ was shown
to possess weak but unusual carcinogenic properties following subcutaneous
injection into rats. The present paper is concerned with a detailed report of
the carcinogenic activity of TCQ administered subcutaneously in rats and by
skin painting in mice.CARCINOGENIC ACTION OF TRICYCLOQUINAZOLINE
MATERIALS AND METHODS
Subcutaneous injection
The compound was injected subcutaneously into male and female inbred
Wistar rats (7 to 11 weeks old) as a suspension (10 mg./ml.) in sterile olive oil,
B.P. Injections were made by inserting the needle through a sterilised portion
of the cervical region and pushing it down into the right axilla. This prevented
leakage of the TCQ suspension.
Initially, it was intended to give monthly injections of 10 mg. of the com-
pound. However, the material was found to persist subcutaneously at the site
of injection and therefore only 4 injections were given (total dosage per animal
of 40 mg.). Animals were examined weekly throughout the period of the experi-
ment (26 months) and at the conclusion, all remaining animals were sacrificed
and the TCQ cysts removed for histological examination.
Skin painting
Mice.-Stock albino mice (Schofield strain) of both sexes and 8 to 10 weeks
old were used. These were obtained commercially and maintained on a cubed
diet (M.R.C. diet 41) supplemented with fresh greenstuffs and carrots, plus water
ad libitum.
Technique
Tricycloquinazoline was prepared as a saturated solution (1 mg./ml.) in
double re-distilled A.R. grade benzene. This solution was freshly prepared every
two to three weeks and kept tightly stoppered in all-glass bottles in the dark.
The hair was removed from the whole back ofthe animal with electric clippers
at the beginning of the experiment and subsequently when necessary. The
solutions were applied dropwise from all-glass tuberculin syringes, care being
taken to ensure even spreading over an area of approximately 4 cm. x 3 cm.
Forty mice, equally divided with respect to sex, were skin painted twice
weekly with 0.3 ml. of the TCQ solution (0.1 per cent w./v.) for 40 weeks. An
equal number of mice were treated with benzene to serve as controls. Mice
were examined, for the presence of tumours, twice weekly during the period of
treatment and the numbers seen were charted. Following completion of the
skin-painting treatment, all survivors were examined weekly until they died
or were killed with tumours. Mice were killed when it was considered that
tumours were apparently malignant. The position of all tumours was recorded
and sections of the apparently malignant tumours were taken for histological
examination. Malignancy of tumours was based on such observations as rapid
enlargement, extensive ulceration, andinvasion ofneighbouring structures.
RESULTS
Subcutaneous injection in rats
Tricycloquinazoline proved to be extremely resistant to metabolism and
subcutaneous cysts containing the compound remained at the site of injection
for the duration of the experiment (22 to 26 months). Quantitative data on the
metabolism of TCQ are not yet available, but attempts were made to recover
the compound 22 months after injection from two rats which had large cysts.
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In each case, approximately 36 mg. out of the 40 mg. injected were recovered
from benzene extracts of the cyst fluids. The recovered compound was shown
to be identical with TCQ by comparison of melting points, mixed melting points,
ultra-violet absorption spectra and RFvalues (Butler, 1958).
Tumours developed in 8 out of 30 rats (27 per cent) which survived fo- 12
months or longer after the first injection. The first tumour appeared 14 months
after the beginning ofthe experiment, whilst the majority arose between the 16th
and 24th months. All these tumours arose in association with the TCQ cysts
(Fig. 2, 3). TCQ cysts were found in all rats that died as well as in the animals
remaining (8) at the completion of the experiment (26 months). In some cases,
the cysts were single and relatively large, whilst in others they were multiple and
proportionately smaller. From an examination of about 50 sections of TCQ
cysts it was possible to identify various stages in the evolution of the tumour.
The inert compound, which was visible in histological section by fluorescence
microscopy, was surround by a fibrous wall which showed some variations in
thickness. In animals without tumours, this fibrous tissue appeared inert. In
some of the younger lesions, a granulomatous reaction with giant cell formation
was seen (Fig. 4).
Histological examination of tumours illustrated their close relation to the
cyst, which was often intact (Fig. 2) and in some places the tumour could be seen
closely blended with the cyst wall (Fig. 5). In all cases, tumours were cellular
sarcomas, probably of fibrous origin, and their irregularity and frequent mitotic
figures left no doubt as to their malignancy (Fig. 6).
Skin painting in Mice
Four of the mice treated with TCQ died within 60 days. The remaining 36
mice survived throughout the experiment or developed tumours and were killed.
Papillomata first began to appear after 110 days (average tumour induction
period 189 days) and by the time skin painting was completed (280 days) 26 mice
(72 per cent) had developed tumours (average tumour yield 5.2). The great
majority of the tumours developed in the area painted, though a few occurred
on the abdomen and face of the animals.
As the nature ofthese latter tumours was in every way similar to those arising
in the skin painted area it appears likely that they arose by transfer of TCQ to
the face and the abdomen by the animal.
The tumours appeared first as papillomas which were mostly of the sessile
variety. Ulceration soon followed and was often accompanied by infection
EXPLANATION OF PLATES
FIG. 2.-The thoracic wall is exposed and shows a tumour mass lying in the subcutaneous
tissue, the animal's head being on the right of the photograph. A small cystic space, which
was found to contain TCQ, can be seen below the main tumour mass.
FIG. 3.-Low-power view to show relation of TCQ to tumour mass. x 12.
FIG. 4.-A portion of the cyst wall showing histiocytic and giant-cell reaction to the foreign
substance. x 110.
FIG. 5.-High-power view of cyst and related cellular tissue. x 85.
FIG. 6. Irregularity of neoplastic elements and presence of numerous tumour giant cells.
X 225.
FIG. 7.-Large ulcerated skin tumour in mouse resulting from painting with TCQ.
FIG. 8.-Low-power view of section of entire tumour shown in Fig. 7. The general structure
of the lesion resembles that seen in keratoacanthoma in man. x 4-5.BRITISH JOURNAL OF CAN(CER.
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(Fig. 7). Section of an entire tumour showed it to be composed of a central
ulcerated area with a central mass of keratin (Fig. 8). This was surrounded by
an area ofproliferating and active squamous epithelium in which much cellular
irregularity and many mitotic figures could be seen. This appearance was in
every way similar to the histological lesion of keratoacanthoma in man, which is
known to retrogress spontaneously. In a number of animals the skin painting
wasstopped to see whether the tumours would persist. Not only didtheypersist,
but extension ofgrowth occurred and the neoplastic tissue in some cases was seen
to invade neighbouring structures. Malignant tumours were observed in 24 out
of 36 mice at risk. Most of these showed the characteristic histological appear-
ance of squamous cell carcinoma with varying degrees ofkeratinisation. A few
tumours were less differentiated and the histological features were those of basal
cell carcinoma.
In the control benzene-painted group of 40 animals one developed a small
simple papilloma on the back
Discussion
The present findings confirm that tricycloquinazoline is carcinogenic for
mouse skin and rat subcutaneous tissue, althoughthe activity of the compound
varies considerably with the route ofadministration. Thus skin painting induces
a high incidence oftumour formation with a short latent period comparable with
that shownby many other skin carcinogens. In contrast, subcutaneous injection
in the rat results in a low tumour incidence with a relatively long latent period.
It may well be that due to the insolubility and unreactivity of TCQ, per-
cutaneous application represents a more favourable route for the presentation of
the carcinogen to tissue. This is supported by the finding that subcutaneously
injected TCQ becomes localised andencysted and little appears to be metabolised.
In this connection, it is interesting that the induction of subcutaneous tumours
with TCQ closely resembles the effects observed by Oppenheimer et al (1955) on
tumour induction withplastics, since many ofthese substances are also chemically
inert. Recently Oppenheimer et al. (1958) have shown that tumours arise from
cells lining connective tissue pockets surrounding subcutaneously embedded
plastics. Although the initial changes were brought about by the plastic films,
the importance of the tissue pockets in the later stages of tumour induction was
apparent since, after a certain time, it was possible to remove the embedded
plastic without influencing tumour formation. These observations are of great
interest since similar histological changes were observed during the induction of
subcutaneous tumours with TCQ and it was found that all of the tumours arose
in close association with TCQ cysts. Thus it would appear that, by virtue ofits
chemical inertness, the carcinogenic activity ofTCQ administered subcutaneously
in the rat is similar tothat ofplastics, although the primary mechanism ofcarcino-
genesis may be quite different. The fact that TCQ possesses a much greater
carcinogenicactivity whenapplied to mouse skin raises the question as to whether
polymeric substances may also show greater activity when applied in the same
way and experiments to investigate this problem are now in progress.
The activity of TCQ on mouse skin is of about the same order as that of
1:2:5:6-dibenzanthracene (Hartwell, 1951) whose carcinogenic properties together
with those ofotherpolycyclichydrocarbonsandalkylatedbenzacridines have been
interpreted in terms of electron densities at the K and L regions (Pullman and
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Pullman, 1955; Lacassagne, Buu Hoi, Daudel and Zajdela, 1956). High activity
is evident in certain members of these series having K regions of appropriate
electron density and in which the L regions are also blocked. In inactive
members the K regions are either absent orhave electron densities ofinappropriate
values. Moreover, the introduction of blocking groups into the K regions of
1:2:5:6-dibenzanthracene suppresses its carcinogenic activity (Oliverio and
Heidelberger, 1958). TCQ has no region which is logically identifiable as an
L region or an unsubstituted K region. It therefore follows that the inter-
pretation of its carcinogenic activity in terms of the union of a K region
with an electrophilic cell-receptor (Pullman and Pullman, 1955) would appear
inapplicable. In this connection it is of interest that preliminary studies on
the metabolism of TCQ on mouse skin have failed to reveal the occurrence of
protein-bound metabolites.
SUMMARY
1. The carcinogenic action of tricycloquinazoline has been investigated by
(a) subcutaneous injection in rats,
(b) skin painting in mice.
2. In rats the tumour incidence is low (27 per cent) and the induction period
long (16-24 months).
3. In mice the tumour incidence is high (72 per cent) and the induction period
shorter (110-280 days).
4. Following subcutaneous injection the TCQ remained localised in a cystic
space and tumours arose from its fibrous wall.
5. This lesion was in every way similar to that observed following the embed-
ding of certain plastic substances.
6. The mode of action of TCQ in relation to other known carcinogens is
discussed.
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